CIViC Compass
Research use only — not FDA-cleared, not medical advice. Always consult FDA-approved labeling and a qualified clinician.
Home/Biomarker

HRR gene mutation (mCRPC)

Gene: HRR · Type: mutation

Indications: Prostate cancer

SensitivityResistanceCIViC Context

FDA Sensitivity Assertions

DrugIndicationRecommendationFDA SourceLink
OlaparibProstate cancerINDICATED
FDA Label
Label
TalazoparibProstate cancerINDICATED
FDA Label
Label
EnzalutamideProstate cancerINDICATED
FDA Label
Label